Bio Medica Laboratories Key Ratios
NSE: BMLL
₹149.90
₹1.90
(1.28%)
As on 11-Nov-2026IST
Market cap
₹189 Cr
Revenue (TTM)
₹43 Cr
P/E Ratio
16
P/B Ratio
6.3
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | -0.06 | 33.14 | -- |
| EBIT | -- | -- | 22.72 | 145.41 | -- |
| Net Profit | -- | -- | 20.25 | 227.08 | -- |
| EPS | -- | -- | 20.25 | 227.08 | -- |
| Book Value | -- | -- | 79.21 | 121.20 | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Mar-26 | Mar-25 | Mar-24 |
| EBIT-Margin
| 37.97 | -- | 43.66 | 37.82 | -- |
| Net Margin
| 23.99 | -- | 27.57 | 25.32 | -- |
| Return on equity
| 74.38 | -- | 57.64 | 65.87 | -- |
| Return on Capital
| 47.71 | -- | 39.14 | 48.73 | -- |
| Return on Assets
| 23.82 | -- | 21.33 | 25.20 | -- |
| Debt to Equity (x)
| -- | -- | 1.51 | 1.02 | -- |
Profitability
ROCE
39.14
Higher than Peers by 21.05
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Bio Medica Laboratories
|
39.14
|
48.73
|
--
|
--
|
--
|
|
Peer Median
|
18.10
|
3.84
|
5.02
|
9.20
|
--
|
ROE
57.64
Higher than Peers by 40.08
Profit after tax / Average Net worth * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Bio Medica Laboratories
|
57.64
|
65.87
|
--
|
--
|
--
|
|
Peer Median
|
17.56
|
5.08
|
1.59
|
9.09
|
--
|
ROA
21.33
Higher than Peers by 11.32
Profit after tax / Average Total assets * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Bio Medica Laboratories
|
21.33
|
25.20
|
--
|
--
|
--
|
|
Peer Median
|
10.01
|
2.19
|
1.46
|
2.77
|
--
|
EBIT Margin
43.66
--
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Bio Medica Laboratories
|
43.66
|
37.82
|
--
|
--
|
--
|
|
Peer Median
|
--
|
2.93
|
3.78
|
4.14
|
--
|
Net Margin
27.57
Higher than Peers by 18.58
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Bio Medica Laboratories
|
27.57
|
25.32
|
--
|
--
|
--
|
|
Peer Median
|
8.99
|
1.96
|
3.27
|
13.99
|
--
|
Cash Profit Margin
30.29
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Bio Medica Laboratories
|
30.29
|
27.95
|
--
|
--
|
--
|
|
Peer Median
|
--
|
0.00
|
0.00
|
0.00
|
--
|
Revenue Growth
12.45
--
Year on year growth in net sales
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Bio Medica Laboratories
|
12.45
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
50.75
|
56.32
|
1,43,500.00
|
--
|
EBIT Growth
29.82
--
Year on year growth in operating profit (EBIT)
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Bio Medica Laboratories
|
29.82
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
75.04
|
59.55
|
-70.24
|
--
|
Net Profit Growth
22.50
--
Year on year growth in profit after tax
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Bio Medica Laboratories
|
22.50
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
39.96
|
-8.68
|
-48.33
|
--
|
EPS Growth
21.40
--
Year on year growth in earnings per share
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Bio Medica Laboratories
|
21.40
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
-21.00
|
--
|
--
|
--
|
Book Value Growth
79.96
--
Year on year growth in book value per share
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Bio Medica Laboratories
|
79.96
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
1.51
Higher than Peers by 1.02
Total debt / Net worth
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Bio Medica Laboratories
|
1.51
|
1.02
|
--
|
--
|
--
|
|
Peer Median
|
0.49
|
--
|
0.63
|
--
|
--
|
Short term debt to equity ratio
0.22
--
(Short term borrowings / Net worth)
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Bio Medica Laboratories
|
0.22
|
0.21
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
2.85
Higher than Peers by 0.35
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Bio Medica Laboratories
|
2.85
|
2.31
|
--
|
--
|
--
|
|
Peer Median
|
2.50
|
2.47
|
2.33
|
5.05
|
--
|
Quick Ratio
0.95
--
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Bio Medica Laboratories
|
0.95
|
0.94
|
--
|
--
|
--
|
|
Peer Median
|
--
|
1.68
|
10.32
|
6.03
|
--
|
Interest Coverage
7.29
Higher than Peers by 2.50
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Bio Medica Laboratories
|
7.29
|
10.71
|
--
|
--
|
--
|
|
Peer Median
|
4.80
|
2.66
|
2.65
|
2.05
|
--
|
Operating Efficiency
Debtors to sales
25.19
--
Debtors outstanding / Net Sales * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Bio Medica Laboratories
|
25.19
|
10.70
|
--
|
--
|
--
|
|
Peer Median
|
--
|
15.37
|
42.99
|
49.21
|
--
|
Asset Turnover
0.77
--
Sales / Average Total Assets
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Bio Medica Laboratories
|
0.77
|
1.00
|
--
|
--
|
--
|
|
Peer Median
|
--
|
1.51
|
1.33
|
0.50
|
--
|
Receivable days
63.33
--
Average Debtors / Sales * 365
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Bio Medica Laboratories
|
63.33
|
39.05
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
230.85
--
Average Inventory / Sales * 365
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Bio Medica Laboratories
|
230.85
|
172.77
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
181.09
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Bio Medica Laboratories
|
181.09
|
159.82
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
113.10
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Bio Medica Laboratories
|
113.10
|
52.00
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Bio Medica Laboratories
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
21.62
|
65.30
|
159.13
|
107.97
|
--
|
Price / Book Value
--
--
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Bio Medica Laboratories
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
2.29
|
2.35
|
3.26
|
2.54
|
--
|
EV/EBITDA
2.45
Lower than Peers by 8.19
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Bio Medica Laboratories
|
2.45
|
1.56
|
--
|
--
|
--
|
|
Peer Median
|
10.64
|
53.35
|
29.43
|
2.43
|
--
|
Market Cap
--
--
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Bio Medica Laboratories
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
139
|
30
|
20
|
13
|
--
|
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
